Invesco Ltd. Argenx Se Transaction History
Invesco Ltd.
- $499 Billion
- Q3 2024
A detailed history of Invesco Ltd. transactions in Argenx Se stock. As of the latest transaction made, Invesco Ltd. holds 433,516 shares of ARGX stock, worth $246 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
433,516
Previous 201,472
115.17%
Holding current value
$246 Million
Previous $86.6 Million
171.36%
% of portfolio
0.05%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding ARGX
# of Institutions
400Shares Held
30.9MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.31 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.41 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$966 Million0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$703 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $31.4B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...